[Choice and use of the new antifungal agents].
作者信息
Meyer R D
机构信息
Departamento de Medicina, Centro Médico Cedars-Sinai, Los Angeles, California.
出版信息
Rev Clin Esp. 1994 Feb;194(2):116-27.
PMID:8008935
Abstract
摘要
相似文献
1
[Choice and use of the new antifungal agents].[新型抗真菌药物的选择与应用]
Rev Clin Esp. 1994 Feb;194(2):116-27.
2
[Antifungal agent resistance of yeasts of clinical significance].[具有临床意义的酵母对抗真菌剂的耐药性]
Rev Clin Esp. 1995 Oct;195 Suppl 3:56-7.
3
Fluconazole and itraconazole: current status and prospects for antifungal therapy.氟康唑和伊曲康唑：抗真菌治疗的现状与前景
Curr Clin Top Infect Dis. 1993;13:74-98.
4
Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.伏立康唑III期临床研究中，伏立康唑、伊曲康唑、氟康唑和两性霉素B对472例患者的1763株酵母菌的体外活性。
Int J Antimicrob Agents. 2008 Dec;32(6):511-4. doi: 10.1016/j.ijantimicag.2008.05.023. Epub 2008 Sep 13.
5
Using oral antifungal agents for severe fungal infections.使用口服抗真菌药物治疗严重真菌感染。
Contemp Intern Med. 1995 May;7(5):25-9, 33-4, 39-40.
6
Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies.血液系统恶性肿瘤中性粒细胞减少患者抗真菌预防的循证综述
J Antimicrob Chemother. 2005 Sep;56 Suppl 1:i23-i32. doi: 10.1093/jac/dki221.
7
Antifungal drugs.抗真菌药物。
Pediatr Rev. 1995 Apr;16(4):123-9. doi: 10.1542/pir.16-4-123.
8
Susceptibility testing of fungi and correlation with clinical outcome.真菌药敏试验及其与临床结果的相关性。
J Chemother. 1997 May;9 Suppl 1:19-24.
9
Antifungal treatment in patients with cancer.癌症患者的抗真菌治疗。
J Intern Med Suppl. 1997;740:89-94.
10
Systemic antifungal drugs.全身性抗真菌药物。
Med Lett Drugs Ther. 1994 Feb 18;36(916):16-8.
Zotero 插件